Biomarkers as Targeted Herbal Drug Discovery: A Pharmacological Approach to Nanomedicines


PrefaceInflammatory Biomarkers: An Important Tool for Herbal Drug DiscoveryANTI-INFLAMMATORY HERBS HAVE PROVEN BENEFICIAL BY COMBATING INFLAMMATORY RESPONSE THAT LEAD TO SEVERE ABNORMALITY IN BODY SYSTEMCHALLENGES WITH HERBAL DRUG DEVELOPMENTBIOMARKERS TARGETED HERBAL DRUG THERAPYDIABETES MELLITUS (DM)CANCERRHEUMATOID ARTHRITIS (RA)CONCLUSIONREFERENCESHerbal Anti-Arthritic Drug Discovery Tool Based on Inflammatory BiomarkersHERBAL PHARMACOTHERAPY IN RAANTIOXIDANT AND ARTHRITISTRADITIONAL MEDICINE AND HERBSCONCLUSIONREFERENCESCurcumin Nanomedicine and Their Application in the Management of DiseaseCURCUMIN NANOFORMULATIONSAPPLICATION OF CURCUMIN NANOFORMULATION IN CANCERAPPLICATION OF CURCUMIN NANOFORMULATION IN INFLAMMATIONAPPLICATION OF CURCUMIN NANOFORMULATION IN MICROBIAL INFECTIONSAPPLICATION OF CURCUMIN NANOFORMULATION IN CARDIAC DISEASESAPPLICATION OF CURCUMIN NANOFORMULATION IN CNS DISORDERSAPPLICATION OF CURCUMIN NANOFORMULATION IN SKIN DISEASEAPPLICATION OF CURCUMIN NANOFORMULATION IN OTHER DISEASESCONCLUSIONREFERENCESUrsolic Acid: A Pentacyclic Triterpene from Plants in NanomedicineCHEMICAL PROPERTYPHYSICAL PROPERTIESPHARMACOKINETICS (PKS)PHARMACOLOGICAL ACTIVITIESANTI-INFLAMMATORY ACTIVITYANTICANCER ACTIVITYHEPATOCELLULAR CARCINOMA (HCC) ACTIVITYANTI-BREAST CANCER THERAPYANTI-CERVICAL CANCER THERAPYBONE REGENERATION ACTIVITYNANOTECHNOLOGYOTHER FORMULATIONSCONCLUSIONREFERENCESPhytoconstituent‑Centered Byproducts and Nanomedicines as Leishmanicidal ScavengersINTRODUCTIONLIFE CYCLE OF LEISHMANIA PROTOZOAL PARASITEPRESENT CHEMOTHERAPY AND RELATED CHALLENGESANT1LEISHMANIAL NATURAL COMPOUNDS AND BYPRODUCTSNANOTECHNOLOGICAL STRATEGIES FOR THE TREATMENT OF LEISHMANIASISFUTURE PROSPECTSREFERENCESDelivery of Herbal Cardiovascular Drugs in the Scenario of Nanotechnology: An InsightCARDIOVASCULAR RISK AND POSSIBLE REASONSHERBAL REMEDIES OF CVDSCONVENTIONAL DELIVERY PROBLEM OF HERBAL DRUGSUSE OF NANOTECHNOLOGY FOR OVERCOMING VARIOUS DELIVERY PROBLEMSLIMITATION OF HERBAL DRUGSCONCLUSIONREFERENCESNigella sativa Encapsulated Nano‑Scaffolds and Their Bioactivity SignificancePhytoconstituent‑Loaded Nanomedicines for Arthritis ManagementOVERVIEW OF NANOMEDICINECHALLENGES WITH HERBAL PHARMACOTHERAPY IN ARTHRITIS TREATMENTNANOTHERAPEUTIC APPROACHES TO ARTHRITIS TREATMENTCARRIER SYSTEMS IN DRUG DELIVERYNANOPARTICLES AS CARRIER SYSTEMS IN DRUG DELIVERYTHERAPEUTIC RELEASE FROM CARRIER SYSTEMSCURRENT LANDSCAPE OF NANOMEDICINE FOR ARTHRITISMETHODS USED FOR PRODUCING NATURAL PRODUCT- BASED NANOMEDICINEGREEN-SYNTHESIZED METAL NANOPARTICLES USING PLANTS FOR ARTHRITIS TREATMENTINCLUSION OF HERBAL BIOACTIVE TO FORMULATE DIFFERENT TYPES OF NANOMEDICINES FOR CONTROLLED DELIVERY SYSTEMSNANOPARTICLE THERAPY IN ARTHRITISSCOPE OF HERBAL NANOMEDICINES IN ARTHRITIS PHARMACOTHERAPYHERBS REPORTED FOR USE IN ARTHRITISFUTURE OF NANOMEDICINE AND DRUG DELIVERY SYSTEM FOR ARTHRITISCONCLUSIONREFERENCESPhytoconstituent‑Based Nanotherapeutics as Ocular Delivery SystemsPHYTOCONSTITUENTS BASED NOVEL OCULAR DRUG DELIVERY SYSTEMSCONCLUSION AND FUTURE PROSPECTSREFERENCESRosmarinic Acid: A Boon in the Management of Cardiovascular DiseaseVARIABILITY OF ROSMARINIC ACID CONTENT IN DIFFERENT SPECIES OF PLANT BELONGING TO FAMILY LABIATAEPHARMACOKINETIC ASPECTS OF ROSMARINIC ACIDPHARMACOLOGICAL ASPECTS OF ROSMARINIC ACIDROLE OF ROSMARINIC ACID IN CARDIOVASCULAR DISEASECONCLUSIONREFERENCESLong-Term Toxicity and Regulations for Bioactive‑Loaded NanomedicinesTOXICITY WITH NATURAL BIOACTIVESTOXICITY WITH BIOACTIVE NANOMATERIALS (NMS)RISK ASSESSMENT AND RISK MINIMIZATION IN NANOMEDICINEREGULATION OF NANOMEDICINESFOOD AND DRUG ADMINISTRATION (FDA) PERSPECTIVESEUROPEAN MEDICINES AGENCY (EMA) PERSPECTIVEREGULATION OF HERBAL NANOMEDICINE PRODUCTS IN INDIACONCLUSIONREFERENCESResveratrol‑Loaded Phytomedicines for Management of CancerPHYTOMEDICINE AND ITS HISTORYRESVERATROL AND ITS ANALOGSIN VITRO PHARMACOLOGICAL PROPERTIES AND ANTICANCER EFFECTS OF RESVERATROLPRECLINICAL STUDIESRESVERATROL-LOADED POLYMERIC NANOTHERAPEUTICS FOR CANCER TREATMENTCONCLUSIONS AND FUTURE PERSPECTIVESREFERENCESThymoquinone-Loaded Nanocarriers for Healthcare ApplicationsTHYMOQUINIONE AS A PROMINENT PHYTOMEDICINEBIOLOGICAL ACTIVITIES OF THYMOQUINONE NANOFORMULATIONCONCLUSIONSREFERENCES